Manufacturer record
Syndicate Pharma 185/B/185/B-1: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Syndicate Pharma 185/B/185/B-1 (Madhya Pradesh) were declared Not of Standard Quality between November 2024 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Syndicate Pharma 185/B/185/B-1 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride syrup 30mg/5ml | 724373Mfg 2024-09 · Exp 2026-08 | MISBRANDED The drug sample is deemed to be MISBRANDED as it is only indicated as approved colour used on the label of the product but failed to indicate the comon name of the colour on the label as required as per Rule 127(2) of Drugs Rules, 1945. Hence the drug is deemed to be Misbranded as per Section 17 of Drugs and Cosmetics Act, 1940, as the drug is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.